Treatment with anti-inflammatory drugs in community-acquired pneumonia

Journal of Internal Medicine
S C A MeijvisW J W Bos

Abstract

Pneumonia exhibits a broad range of severity, from mildly symptomatic at one end to fulminant septic shock and death at the other. Although an adequate inflammatory response is necessary for the clearance of microorganisms, excessive inflammation can lead to ongoing local and systemic damage. Because of this extended inflammatory response despite appropriate antibiotic therapy, as well as increasing antibiotic resistance, adjuvant therapy for pneumonia that can favourably modify the immune response has become an increasingly relevant approach to improve prognosis. Different adjuvant treatment options for pneumonia have recently been proposed. Promising treatment options include corticosteroids, statins, macrolides and Toll-like receptor antagonists. The aim of this review is to summarize the inflammatory response during pneumonia and discuss the current knowledge and future perspectives regarding the anti-inflammatory treatment options for patients with pneumonia.

References

Jan 10, 1996·JAMA : the Journal of the American Medical Association·M J FineW N Kapoor
Jan 1, 1997·Infection and Immunity·K TakashimaK Yamaguchi
Feb 25, 2000·Therapeutic Drug Monitoring·A Kelso
Aug 30, 2000·Nature·M L Cohen
Dec 2, 2000·Nature Medicine·B KwakF Mach
Apr 5, 2001·The New England Journal of Medicine·M J Walport
Apr 12, 2001·The New England Journal of Medicine·M J Walport
May 12, 2001·Science·E S Istvan, J Deisenhofer
Jun 14, 2001·Lancet·J Parkin, B Cohen
Aug 30, 2001·Archives of Internal Medicine·G W WatererR G Wunderink
Jan 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jerome GalonStefan R Bornstein
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·José A MartínezJosep Mensa
Feb 18, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Isaac Ginsburg
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Eugene LinMaurice A Mufson
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Robert D HardyOctavio Ramilo
May 15, 2003·American Journal of Respiratory and Critical Care Medicine·Bernhard M SchaafKlaus Dalhoff
Sep 11, 2003·Clinical and Diagnostic Laboratory Immunology·Silvia Fernández-SerranoFrederic Manresa
Oct 11, 2003·The Pediatric Infectious Disease Journal·Carla M OdioPatricio Alvarez
Jun 5, 2004·The European Respiratory Journal·E KostadimaA Papamichalopoulos
Jun 9, 2004·American Journal of Respiratory and Critical Care Medicine·Larry M BaddourUNKNOWN International Pneumococcal Study Group
Nov 24, 2004·American Journal of Respiratory and Critical Care Medicine·Marco ConfalonieriG Umberto Meduri
Dec 22, 2004·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·K WeissJ Tremblay
Oct 21, 2005·The New England Journal of Medicine·Turk Rhen, John A Cidlowski
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maurice A Mufson, Ronald J Stanek
Feb 4, 2006·The European Respiratory Journal·J AspaUNKNOWN Pneumococcal Pneumonia in Spain Study Group
Aug 10, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R DwyerM Kalin
Jun 15, 2007·Lancet·Jane Armitage
Aug 11, 2007·The European Respiratory Journal·C Garcia-VidalJ Garau
Dec 7, 2007·Intensive Care Medicine·R Phillip DellingerJean-Louis Vincent
Dec 12, 2007·Seminars in Immunopathology·Hongmei GaoSimon J Finney
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Jan 9, 2008·Immunology and Cell Biology·Fang Fang YuanJohn Stephen Sullivan
Mar 21, 2008·American Journal of Physiology. Renal Physiology·Pierre C Dagher, David P Basile

❮ Previous
Next ❯

Citations

May 15, 2013·The Journal of Infection·D P R TroemanJ J Oosterheert
Feb 11, 2014·Journal of Pharmaceutical Sciences·Sie Huey LeeReginald B H Tan
Jan 10, 2014·British Journal of Clinical Pharmacology·Simone M C SpoorenbergEwoudt M W van de Garde
Apr 8, 2015·Respiratory Research·María-José LorenzoRosario Menéndez
Jun 25, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Nobuyuki HoritaTakeshi Kaneko
Oct 8, 2016·Critical Care : the Official Journal of the Critical Care Forum·Elena PrinaAntoni Torres
Oct 25, 2016·PPAR Research·Aravind T ReddyRaju C Reddy
Dec 6, 2017·Scientific Reports·Yang ZhangQing-Zhen Han
Jan 12, 2019·Current Opinion in Cardiology·Benjamin BartlettGirish Dwivedi
Oct 5, 2017·Clinical Medicine : Journal of the Royal College of Physicians of London·Frances S GrudzinskaDavid R Thickett
Jan 25, 2020·Hospital Practice·David NoraPedro Póvoa
Oct 3, 2017·Experimental and Therapeutic Medicine·Ming LiZhuang-Gui Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here